Notification Letter and Reply Form to Registered Shareholders
Filed with HKEX · Stock code 455 · · 2 pages · English and Chinese
The English and Chinese versions of the Company’s Current Corporate Communications are now available on the Company’s website at http://www.tiandapharma.com and the website of The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) at www.hkexnews.hk respectively (the “Website Version”). The Company strongly recommends you to access the Website Version of the Current Corporate Communication
Tianda Pharmaceuticals Ltd. on 6ix
Earlier from Tianda Pharmaceuticals
- Interim Report 2026
- Tianda Pharma Announces 2022/23 Interim Results
- Tianda Pharmaceuticals Annual Results 2022
- Acquiring Xiaoer Qingre Zhike granule, Tianda Pharmaceuticals continues to broaden its product mix and perfect its Chinese medicine whole industry chain layout
- Tianda Pharmaceuticals acquires Yeung & Young Medicare and Qi's Living, establishing long-term cooperation
Later from Tianda Pharmaceuticals
- Notification Letter and Request Form to Non-Registered Shareholders
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September, 2026
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October, 2026
Follow Tianda Pharmaceuticals into a list and get an email when it puts out news.
Follow Tianda Pharmaceuticals